Back to Articles
45492026 Q3PrimeJGAAP

EIKEN CHEMICAL (4549) FY2026 Q3 Earnings Report

For FY2026 Q3, revenue came to ¥31.4B (+2.4% year on year) and operating income ¥2.8B (+5.5%). The segment drivers and cash flow follow.

EIKEN CHEMICAL CO.,LTD.

Pharmaceutical


Quick View

MetricCurrentPriorYoY
Revenue¥313.8B¥306.4B+2.4%
Operating Income¥27.8B¥26.3B+5.5%
Ordinary Income¥27.4B¥28.4B−3.4%
Net Income¥37.2B¥21.2B+75.9%
ROE8.5%4.9%-

Executive Summary

Performance Drivers

Segment Analysis

Key Metrics

Cash Flow Analysis

Earnings Quality

Guidance Update

Shareholder Returns

Catalysts

Industry Benchmark (Reference - Proprietary Data)

Risk Factors

Key Takeaways from Earnings


**

EIKEN CHEMICAL (4549) FY2026 Q3 Earnings Report